The Predictive Value of Soluble Fms-Like Tyrosine Kinase-1 for Prognosis in COVID-19 Patients
These findings underscore the potential of sFlt-1 as a valuable biomarker for clinical decision-making in managing COVID-19 patients. Future studies should focus on the clinical application of sFlt-1 and explore its underlying mechanisms to enhance patient management strategies.
Authors
- Yingfei Wang (ORCID: https://orcid.org/0000-0002-8723-252X)
- Flair Donglai Shi
- Bo Liu (ORCID: https://orcid.org/0000-0002-8900-7668)
- Chunlian Lai
- Zhao Liu (ORCID: https://orcid.org/0009-0000-5103-9923)
- Pan Wen (ORCID: https://orcid.org/0000-0003-0321-1332)
- Yingmin Ma (ORCID: https://orcid.org/0000-0002-2311-9712)
- Nan Geng (ORCID: https://orcid.org/0000-0001-7691-3840)
- Hongbo Shi (ORCID: https://orcid.org/0000-0002-0538-3026)
Institutions
- Capital Medical University (CN)
- Beijing YouAn Hospital (CN)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/jir.s504751
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00